Evidently, dopamine transporter (DAT) is a key molecule in psychopharmacological treatment of ADHD, pivotal in i) regulating the DA level within synaptic cleft and ii) maintaining presynaptic DA function through synthesis and storage. Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.